You are here

  • Home
  • Archive
  • Volume 78, Issue 11
  • Response to: ‘Comment on: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al’ by Isenberg

Article metrics

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Comment on: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al’ by Isenberg
Free

 

Online download statistics by month:

Online download statistics by month: October 2018 to March 2024

AbstractFullPdf
Oct 2018276277
Nov 20185323214
Dec 201867495
Jan 201941972
Feb 2019835143
Mar 2019100073
Apr 201993274
May 201995320
Jun 201960352
Jul 201940221
Aug 201942110
Sep 201952732
Oct 201932417322
Nov 2019787716
Dec 2019545215
Jan 2020303012
Feb 202027256
Mar 202020204
Apr 202027275
May 202015153
Jun 202018177
Jul 202021218
Aug 202013137
Sep 202033236
Oct 202027276
Nov 2020151513
Dec 202020182
Jan 202115147
Feb 2021993
Mar 202112128
Apr 20215512
May 2021995
Jun 202137375
Jul 202114142
Aug 202111116
Sep 202112126
Oct 202110920
Nov 2021141414
Dec 2021774
Jan 202216175
Feb 2022995
Mar 2022262619
Apr 202222219
May 2022393917
Jun 202222225
Jul 202217172
Aug 202228273
Sep 2022262513
Oct 2022242410
Nov 202212128
Dec 202220169
Jan 2023993
Feb 202337372
Mar 2023552
Apr 2023554
May 2023663
Jun 2023886
Jul 2023886
Aug 202316164
Sep 2023882
Oct 202312126
Nov 202314145
Dec 202325266
Jan 202419118
Feb 202410103
Mar 2024121140
Total89061263472